ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025
Risk Factors of Developing Dysmobility Syndrome in Elderly Patients with Type 2 Diabetes Mellitus.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanistic Pathways Linking Type 2 Diabetes Mellitus, Hypertension, and Osteoarthritis to Falls in Older Adults: A Scoping Review.Healthcare (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Population aging is a worldwide phenomenon, and aging-related diseases need to be given great attention. Dysmobility syndrome (DMS) was considered as a comprehensive approach to evaluate the condition of musculoskeletal system and adverse health problems in older population. Aim: There is little research data on the correlation between type 2 diabetes and DMS in the elderly. The purpose of our study is to identify the risk factors for dysmobility syndrome (DMS) in elderly patients with type 2 diabetes mellitus (T2DM). Methods: A total of 262 patients aged >60 years who were diagnosed with T2DM at our department were included in a cross-sectional study and were divided into groups according to the development of DMS and the number of presentations, including osteoporosis, low muscle strength and mass, obesity, falls, and slow walking speed. Consequently, 128 patients with non-DMS were assigned to group A, 84 patients with to 2-3 presentations (without falls) were assigned to group B, and 50 patients with to 4-5 presentations (without falls) were assigned to group C. Demographic data, diabetes-related complications, and history of falls in the past year were compared to identify risk factors for developing DMS in elderly T2DM patients. Results: It showed that 50.4% of the elderly T2DM patients developed DMS, and 25.2% of them had at least one episode of falling. The average age of the patients and the occurrence of diabetic nephropathy were higher, while diastolic blood pressure and 25-(OH) vitamin D serum calcium and albumin levels were lower in group C than in group A and B(p < 0.05). The occurrence of falls was lower in group A than in the other groups (p = 0.001). Conclusion: Aging, 25 (OH) vitamin D deficiency, and accidental fall history are associated with an increased risk of DMS in elderly patients with T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.